GO:0150062 BP 2.84e-09   4/214     4/29107 D07 complement-mediated synapse pruning      712.0, 718.0, 3684.0, 54209.0 
GO:0006911 BP 3.00e-08   7/214    26/29107 D07 phagocytosis, engulfment                 199.0, 3684.0, 3689.0, 4481.0, 9938.0, 51411.0, 54209.0 
GO:0032703 BP 3.83e-08   6/214    27/29107 D08 negative regulation of interleukin-2 production 5788.0, 7128.0, 7805.0, 11006.0, 11326.0, 84868.0 
GO:0001774 BP 4.85e-08   7/214    28/29107 D06 microglial cell activation               199.0, 712.0, 3684.0, 3689.0, 7096.0, 7097.0, 54209.0 
GO:0019886 BP 7.54e-08   6/214    30/29107 D05 antigen processing and presentation of exogenous peptide antigen via MHC class II 972.0, 1520.0, 3108.0, 3109.0, 3113.0, 3122.0 
GO:0006935 BP 1.63e-07   9/214   113/29107 D03 chemotaxis                               719.0, 1524.0, 1794.0, 2242.0, 3071.0, 5724.0, 6693.0, 58191.0, 123920.0 
GO:0032743 BP 1.67e-07   7/214    34/29107 D08 positive regulation of interleukin-2 production 861.0, 920.0, 942.0, 5788.0, 54440.0, 64581.0, 84433.0 
GO:0002250 BP 1.71e-07  19/214   189/29107 D03 adaptive immune response                 695.0, 920.0, 942.0, 1520.0, 1524.0, 3108.0, 3109.0, 3113.0, 3122.0, 3903.0, 4067.0, 5294.0, 6494.0, 6850.0, 8832.0, 10859.0, 11006.0, 84868.0, 89790.0 
GO:0051056 BP 1.90e-07  10/214   115/29107 D07 regulation of small GTPase mediated signal transduction 1794.0, 6494.0, 7409.0, 23526.0, 50619.0, 81704.0, 89846.0, 117289.0, 221472.0, 257106.0 
GO:0098883 BP 1.94e-07   4/214     8/29107 D06 synapse pruning                          712.0, 713.0, 714.0, 1524.0 
GO:0006954 BP 2.09e-07  33/214   387/29107 D04 inflammatory response                    140.0, 199.0, 718.0, 719.0, 720.0, 929.0, 1436.0, 1524.0, 1535.0, 1536.0, 3055.0, 3663.0, 3689.0, 4261.0, 4973.0, 5294.0, 5724.0, 5742.0, 6696.0, 7040.0, 7096.0, 7097.0, 7128.0, 7133.0, 10312.0, 23166.0, 29760.0, 51284.0, 57413.0, 64581.0, 81793.0, 84868.0, 122618.0 
GO:0045766 BP 2.15e-07  10/214   153/29107 D07 positive regulation of angiogenesis      718.0, 719.0, 861.0, 1524.0, 1536.0, 2022.0, 3099.0, 3687.0, 4814.0, 7048.0 
GO:0032481 BP 2.19e-07   5/214    19/29107 D08 positive regulation of type I interferon production 929.0, 3663.0, 6850.0, 115004.0, 340061.0 
GO:0030217 BP 2.39e-07   6/214    36/29107 D07 T cell differentiation                   860.0, 920.0, 5788.0, 7409.0, 10312.0, 54567.0 
GO:0031663 BP 2.39e-07   7/214    36/29107 D06 lipopolysaccharide-mediated signaling pathway 929.0, 3055.0, 4067.0, 5724.0, 6688.0, 7040.0, 7097.0 
GO:0042102 BP 2.60e-07   9/214    59/29107 D09 positive regulation of T cell proliferation 199.0, 942.0, 3071.0, 3109.0, 3113.0, 5788.0, 54440.0, 84433.0, 84868.0 
GO:0006955 BP 2.78e-07  24/214   291/29107 D02 immune response                          714.0, 718.0, 920.0, 942.0, 1520.0, 1524.0, 2214.0, 2217.0, 2533.0, 3113.0, 3122.0, 3394.0, 3937.0, 4055.0, 4261.0, 5724.0, 6693.0, 7096.0, 7097.0, 7133.0, 7409.0, 10261.0, 10346.0, 81793.0 
GO:0002224 BP 2.91e-07   5/214    20/29107 D07 toll-like receptor signaling pathway     1520.0, 7096.0, 7097.0, 51284.0, 81793.0 
GO:0032930 BP 2.91e-07   6/214    20/29107 D08 positive regulation of superoxide anion generation 1535.0, 3684.0, 3689.0, 6850.0, 7040.0, 64581.0 
GO:0050731 BP 3.46e-07   8/214    90/29107 D10 positive regulation of peptidyl-tyrosine phosphorylation 920.0, 972.0, 3678.0, 5788.0, 6850.0, 7040.0, 54209.0, 64581.0 
GO:0045087 BP 3.59e-07  33/214   461/29107 D06 innate immune response                   684.0, 695.0, 712.0, 713.0, 714.0, 720.0, 929.0, 1436.0, 1524.0, 1535.0, 1536.0, 2242.0, 3055.0, 3663.0, 3684.0, 4067.0, 5294.0, 6850.0, 7096.0, 7097.0, 8832.0, 10346.0, 10475.0, 51284.0, 51296.0, 81793.0, 84282.0, 84868.0, 89790.0, 115004.0, 122618.0, 219972.0, 340061.0 
GO:0032757 BP 3.67e-07   7/214    62/29107 D08 positive regulation of interleukin-8 production 929.0, 972.0, 6850.0, 7096.0, 7097.0, 51284.0, 64581.0 
GO:0150064 BP 3.92e-07   3/214     3/29107 D04 vertebrate eye-specific patterning       712.0, 718.0, 3684.0 
GO:0071727 BP 3.92e-07   3/214     3/29107 D08 cellular response to triacyl bacterial lipopeptide 929.0, 7096.0, 7097.0 
GO:0050853 BP 3.92e-07  10/214    39/29107 D10 B cell receptor signaling pathway        695.0, 3071.0, 4067.0, 4332.0, 4773.0, 5777.0, 5788.0, 6850.0, 29760.0, 89857.0 
GO:0007229 BP 4.46e-07  11/214    93/29107 D06 integrin-mediated signaling pathway      2533.0, 3055.0, 3678.0, 3684.0, 3687.0, 3689.0, 6850.0, 7094.0, 7409.0, 83706.0, 84106.0 
GO:0032755 BP 4.46e-07   9/214    93/29107 D08 positive regulation of interleukin-6 production 199.0, 972.0, 1535.0, 5724.0, 6850.0, 7096.0, 7097.0, 51284.0, 64581.0 
GO:0030225 BP 4.88e-07   5/214    22/29107 D06 macrophage differentiation               841.0, 920.0, 1436.0, 6688.0, 139716.0 
GO:0042130 BP 5.34e-07   7/214    41/29107 D09 negative regulation of T cell proliferation 942.0, 5777.0, 6693.0, 10859.0, 11006.0, 11326.0, 84868.0 
GO:0032735 BP 5.34e-07   6/214    41/29107 D08 positive regulation of interleukin-12 production 3394.0, 3663.0, 6850.0, 7097.0, 7805.0, 64581.0 
GO:0002862 BP 6.19e-07   5/214    23/29107 D08 negative regulation of inflammatory response to antigenic stimulus 3055.0, 4067.0, 6850.0, 54209.0, 79651.0 
GO:0030890 BP 6.19e-07   6/214    42/29107 D09 positive regulation of B cell proliferation 972.0, 3071.0, 4773.0, 5788.0, 54440.0, 84433.0 
GO:0032722 BP 6.19e-07   6/214    42/29107 D08 positive regulation of chemokine production 199.0, 972.0, 1436.0, 7097.0, 51284.0, 84868.0 
GO:0007155 BP 7.61e-07  16/214   488/29107 D02 cell adhesion                            920.0, 1441.0, 1524.0, 2022.0, 2242.0, 3055.0, 3678.0, 3684.0, 3687.0, 3689.0, 4814.0, 6404.0, 6696.0, 23166.0, 27181.0, 89790.0 
GO:1901224 BP 7.72e-07   7/214    69/29107 D08 positive regulation of NIK/NF-kappaB signaling 929.0, 942.0, 7097.0, 7805.0, 51284.0, 54209.0, 84868.0 
GO:0034341 BP 7.78e-07   5/214    24/29107 D05 response to interferon-gamma             684.0, 972.0, 4261.0, 6672.0, 58191.0 
GO:0006898 BP 8.52e-07   7/214    70/29107 D06 receptor-mediated endocytosis            929.0, 3684.0, 3689.0, 4481.0, 7048.0, 23166.0, 58191.0 
GO:0032760 BP 9.08e-07  12/214   102/29107 D09 positive regulation of tumor necrosis factor production 929.0, 1535.0, 1536.0, 5724.0, 5788.0, 6693.0, 6850.0, 7096.0, 7097.0, 54440.0, 64581.0, 84868.0 
GO:0032729 BP 1.03e-06   8/214    72/29107 D08 positive regulation of interferon-gamma production 929.0, 3113.0, 3394.0, 10859.0, 51284.0, 54440.0, 64581.0, 84868.0 
GO:0019221 BP 1.14e-06   9/214   142/29107 D06 cytokine-mediated signaling pathway      1436.0, 1441.0, 3055.0, 3587.0, 3597.0, 3663.0, 5777.0, 6776.0, 10859.0 
GO:0007165 BP 1.19e-06  25/214  1063/29107 D04 signal transduction                      140.0, 718.0, 920.0, 963.0, 1436.0, 1441.0, 3635.0, 4055.0, 4067.0, 6195.0, 6494.0, 6693.0, 6696.0, 7096.0, 7097.0, 9938.0, 10859.0, 27181.0, 54518.0, 54567.0, 57413.0, 58191.0, 64926.0, 117289.0, 123920.0 
GO:0043123 BP 1.30e-06  10/214   186/29107 D08 positive regulation of I-kappaB kinase/NF-kappaB signaling 684.0, 841.0, 843.0, 920.0, 972.0, 4055.0, 10346.0, 10475.0, 64581.0, 84433.0 
GO:0045579 BP 1.34e-06   4/214    12/29107 D09 positive regulation of B cell differentiation 695.0, 3071.0, 3635.0, 6850.0 
GO:0002774 BP 1.56e-06   3/214     4/29107 D08 Fc receptor mediated inhibitory signaling pathway 4067.0, 10859.0, 11006.0 
GO:0071226 BP 1.56e-06   3/214     4/29107 D05 cellular response to molecule of fungal origin 695.0, 6850.0, 64581.0 
GO:0043315 BP 1.56e-06   3/214     4/29107 D11 positive regulation of neutrophil degranulation 3684.0, 3689.0, 5724.0 
GO:0071407 BP 1.58e-06   6/214    49/29107 D05 cellular response to organic cyclic compound 841.0, 1535.0, 4481.0, 7040.0, 53829.0, 340061.0 
GO:0007159 BP 1.76e-06   5/214    28/29107 D04 leukocyte cell-cell adhesion             3689.0, 4973.0, 5788.0, 6850.0, 83706.0 
GO:0034113 BP 1.76e-06   5/214    28/29107 D04 heterotypic cell-cell adhesion           3678.0, 3687.0, 3689.0, 4814.0, 5788.0 
GO:0001934 BP 1.81e-06  10/214   193/29107 D09 positive regulation of protein phosphorylation 199.0, 718.0, 920.0, 972.0, 1436.0, 2022.0, 4067.0, 7040.0, 54209.0, 338773.0 
GO:0001775 BP 1.93e-06   4/214    13/29107 D02 cell activation                          6850.0, 7096.0, 7097.0, 64581.0 
GO:0097242 BP 1.93e-06   4/214    13/29107 D02 amyloid-beta clearance                   718.0, 3684.0, 3689.0, 4481.0 
GO:0035589 BP 2.68e-06   4/214    14/29107 D07 G protein-coupled purinergic nucleotide receptor signaling pathway 2857.0, 5724.0, 53829.0, 64805.0 
GO:0097028 BP 2.68e-06   4/214    14/29107 D06 dendritic cell differentiation           3394.0, 4067.0, 10859.0, 54209.0 
GO:0030097 BP 2.83e-06   6/214    54/29107 D05 hemopoiesis                              678.0, 860.0, 861.0, 1436.0, 6404.0, 6886.0 
GO:0051607 BP 3.11e-06  10/214   205/29107 D07 defense response to virus                684.0, 3663.0, 3687.0, 5788.0, 7097.0, 10346.0, 10859.0, 51284.0, 115004.0, 340061.0 
GO:0050870 BP 3.51e-06   5/214    32/29107 D08 positive regulation of T cell activation 920.0, 3108.0, 3109.0, 3113.0, 3122.0 
GO:0033630 BP 3.64e-06   4/214    15/29107 D06 positive regulation of cell adhesion mediated by integrin 3071.0, 5777.0, 6850.0, 64805.0 
GO:0043378 BP 3.88e-06   3/214     5/29107 D11 positive regulation of CD8-positive, alpha-beta T cell differentiation 861.0, 3071.0, 11006.0 
GO:0034154 BP 3.88e-06   3/214     5/29107 D08 toll-like receptor 7 signaling pathway   51284.0, 84868.0, 118788.0 
GO:0008015 BP 4.80e-06   5/214    34/29107 D04 blood circulation                        719.0, 2313.0, 4973.0, 26509.0, 54567.0 
GO:0006958 BP 4.80e-06   5/214    34/29107 D08 complement activation, classical pathway 712.0, 713.0, 714.0, 718.0, 720.0 
GO:0002503 BP 4.82e-06   4/214    16/29107 D08 peptide antigen assembly with MHC class II protein complex 3108.0, 3109.0, 3113.0, 3122.0 
GO:0002244 BP 5.29e-06   6/214    60/29107 D04 hematopoietic progenitor cell differentiation 1436.0, 5777.0, 5788.0, 7040.0, 54502.0, 122618.0 
GO:0007169 BP 5.33e-06   8/214   129/29107 D07 transmembrane receptor protein tyrosine kinase signaling pathway 920.0, 1436.0, 2242.0, 3055.0, 3937.0, 4067.0, 6850.0, 29760.0 
GO:0006956 BP 6.27e-06   4/214    17/29107 D07 complement activation                    712.0, 713.0, 718.0, 720.0 
GO:0002381 BP 6.27e-06   4/214    17/29107 D07 immunoglobulin production involved in immunoglobulin-mediated immune response 3108.0, 3109.0, 3113.0, 3122.0 
GO:0009611 BP 7.05e-06   6/214    63/29107 D03 response to wounding                     140.0, 678.0, 1524.0, 7040.0, 10894.0, 57413.0 
GO:0007166 BP 7.09e-06  10/214   225/29107 D05 cell surface receptor signaling pathway  920.0, 929.0, 942.0, 2212.0, 2214.0, 3597.0, 5788.0, 6693.0, 10261.0, 284021.0 
GO:0030889 BP 8.02e-06   4/214    18/29107 D09 negative regulation of B cell proliferation 695.0, 3635.0, 4067.0, 4332.0 
GO:0050921 BP 8.02e-06   4/214    18/29107 D06 positive regulation of chemotaxis        199.0, 7040.0, 54209.0, 64805.0 
GO:0050850 BP 8.02e-06   4/214    18/29107 D08 positive regulation of calcium-mediated signaling 920.0, 6850.0, 54209.0, 64581.0 
GO:0032715 BP 8.47e-06   6/214    65/29107 D08 negative regulation of interleukin-6 production 3071.0, 3635.0, 5777.0, 7128.0, 11006.0, 84868.0 
GO:0032728 BP 9.63e-06   5/214    39/29107 D09 positive regulation of interferon-beta production 3663.0, 7097.0, 51284.0, 84282.0, 340061.0 
GO:0031295 BP 9.63e-06   5/214    39/29107 D09 T cell costimulation                     942.0, 4067.0, 5777.0, 7409.0, 84433.0 
GO:0010628 BP 1.18e-05  14/214   472/29107 D06 positive regulation of gene expression   860.0, 972.0, 2022.0, 3687.0, 4773.0, 6688.0, 7040.0, 7097.0, 10859.0, 29760.0, 54209.0, 54567.0, 64581.0, 338773.0 
GO:0032733 BP 1.24e-05   5/214    41/29107 D08 positive regulation of interleukin-10 production 6850.0, 7097.0, 54209.0, 54440.0, 64581.0 
GO:0002755 BP 1.25e-05   4/214    20/29107 D08 MyD88-dependent toll-like receptor signaling pathway 695.0, 7096.0, 7097.0, 81793.0 
GO:1904141 BP 1.34e-05   3/214     7/29107 D10 positive regulation of microglial cell migration 1524.0, 54209.0, 64805.0 
GO:0034136 BP 1.34e-05   3/214     7/29107 D09 negative regulation of toll-like receptor 2 signaling pathway 4067.0, 7128.0, 54209.0 
GO:0045588 BP 1.34e-05   3/214     7/29107 D10 positive regulation of gamma-delta T cell differentiation 3071.0, 5788.0, 6850.0 
GO:0038096 BP 1.54e-05   4/214    21/29107 D10 Fc-gamma receptor signaling pathway involved in phagocytosis 3055.0, 4067.0, 6850.0, 7409.0 
GO:0042110 BP 1.57e-05   5/214    43/29107 D05 T cell activation                        841.0, 920.0, 5294.0, 5788.0, 64581.0 
GO:0070527 BP 1.76e-05   5/214    44/29107 D05 platelet aggregation                     5294.0, 5777.0, 7094.0, 64805.0, 83706.0 
GO:0050869 BP 2.14e-05   3/214     8/29107 D08 negative regulation of B cell activation 7128.0, 7805.0, 64092.0 
GO:0045893 BP 2.20e-05  16/214   637/29107 D10 positive regulation of transcription, DNA-templated 391.0, 860.0, 861.0, 920.0, 942.0, 972.0, 2313.0, 4261.0, 4773.0, 6195.0, 6672.0, 6696.0, 6886.0, 7040.0, 10346.0, 10475.0 
GO:0038095 BP 2.25e-05   4/214    23/29107 D08 Fc-epsilon receptor signaling pathway    695.0, 4067.0, 6850.0, 7409.0 
GO:0030593 BP 2.43e-05   6/214    78/29107 D09 neutrophil chemotaxis                    1441.0, 3071.0, 3689.0, 5294.0, 6850.0, 7409.0 
GO:0008284 BP 2.60e-05  14/214   507/29107 D05 positive regulation of cell population proliferation 199.0, 391.0, 860.0, 942.0, 1436.0, 3055.0, 3597.0, 3687.0, 4067.0, 5777.0, 7040.0, 7048.0, 10312.0, 64581.0 
GO:0032753 BP 3.18e-05   4/214    25/29107 D08 positive regulation of interleukin-4 production 942.0, 6850.0, 54440.0, 84868.0 
GO:0050764 BP 3.19e-05   3/214     9/29107 D06 regulation of phagocytosis               3055.0, 5788.0, 6850.0 
GO:0071222 BP 3.49e-05   8/214   167/29107 D06 cellular response to lipopolysaccharide  929.0, 942.0, 1524.0, 3394.0, 7128.0, 7133.0, 10859.0, 84868.0 
GO:0071223 BP 4.53e-05   3/214    10/29107 D06 cellular response to lipoteichoic acid   929.0, 7097.0, 54209.0 
GO:0018108 BP 4.69e-05   7/214   128/29107 D09 peptidyl-tyrosine phosphorylation        695.0, 1436.0, 2242.0, 3055.0, 4067.0, 5777.0, 6850.0 
GO:0043313 BP 5.38e-05   2/214     2/29107 D10 regulation of neutrophil degranulation   6850.0, 84106.0 
GO:0042495 BP 5.38e-05   2/214     2/29107 D08 detection of triacyl bacterial lipopeptide 7096.0, 7097.0 
GO:0002573 BP 5.38e-05   2/214     2/29107 D05 myeloid leukocyte differentiation        861.0, 6688.0 
GO:1904139 BP 5.38e-05   2/214     2/29107 D09 regulation of microglial cell migration  1524.0, 64805.0 
GO:1904093 BP 5.38e-05   2/214     2/29107 D07 negative regulation of autophagic cell death 7805.0, 54209.0 
GO:0050852 BP 5.83e-05   6/214    91/29107 D10 T cell receptor signaling pathway        1967.0, 2533.0, 3635.0, 3937.0, 5788.0, 84106.0 
GO:0001525 BP 6.12e-05   9/214   233/29107 D03 angiogenesis                             841.0, 1296.0, 2022.0, 3678.0, 4814.0, 5294.0, 6850.0, 6886.0, 54567.0 
GO:0045059 BP 6.19e-05   3/214    11/29107 D04 positive thymic T cell selection         972.0, 1794.0, 5788.0 
GO:0045577 BP 6.19e-05   3/214    11/29107 D08 regulation of B cell differentiation     678.0, 5777.0, 84433.0 
GO:0045060 BP 6.19e-05   3/214    11/29107 D04 negative thymic T cell selection         972.0, 1794.0, 5788.0 
GO:0045657 BP 6.19e-05   3/214    11/29107 D09 positive regulation of monocyte differentiation 920.0, 972.0, 2242.0 
GO:1900015 BP 6.19e-05   3/214    11/29107 D07 regulation of cytokine production involved in inflammatory response 240.0, 54209.0, 122618.0 
GO:0046598 BP 6.19e-05   3/214    11/29107 D06 positive regulation of viral entry into host cell 920.0, 972.0, 10475.0 
GO:0007202 BP 6.70e-05   4/214    30/29107 D09 activation of phospholipase C activity   942.0, 2769.0, 5330.0, 64805.0 
GO:0048661 BP 8.06e-05   5/214    60/29107 D06 positive regulation of smooth muscle cell proliferation 199.0, 1535.0, 5724.0, 7040.0, 7048.0 
GO:0060100 BP 8.21e-05   3/214    12/29107 D08 positive regulation of phagocytosis, engulfment 718.0, 3071.0, 54209.0 
GO:0060907 BP 8.21e-05   3/214    12/29107 D10 positive regulation of macrophage cytokine production 972.0, 7805.0, 10859.0 
GO:0030335 BP 8.71e-05   9/214   244/29107 D07 positive regulation of cell migration    199.0, 1436.0, 3687.0, 4067.0, 4641.0, 7040.0, 58191.0, 64581.0, 83706.0 
GO:0048678 BP 9.83e-05   4/214    33/29107 D04 response to axon injury                  199.0, 4067.0, 54209.0, 64805.0 
GO:0034144 BP 1.06e-04   3/214    13/29107 D09 negative regulation of toll-like receptor 4 signaling pathway 4067.0, 7128.0, 54209.0 
GO:0010803 BP 1.06e-04   3/214    13/29107 D07 regulation of tumor necrosis factor-mediated signaling pathway 841.0, 6850.0, 7128.0 
GO:0042113 BP 1.11e-04   4/214    34/29107 D05 B cell activation                        684.0, 695.0, 841.0, 942.0 
GO:0008360 BP 1.22e-04   7/214   149/29107 D06 regulation of cell shape                 391.0, 1436.0, 2242.0, 3055.0, 3689.0, 89846.0, 221472.0 
GO:0051092 BP 1.38e-04   7/214   152/29107 D12 positive regulation of NF-kappaB transcription factor activity 695.0, 1524.0, 7097.0, 10346.0, 10475.0, 64581.0, 84433.0 
GO:2000363 BP 1.61e-04   2/214     3/29107 D06 positive regulation of prostaglandin-E synthase activity 3684.0, 3689.0 
GO:0045058 BP 1.61e-04   2/214     3/29107 D02 T cell selection                         920.0, 972.0 
GO:1904845 BP 1.61e-04   2/214     3/29107 D07 cellular response to L-glutamine         1535.0, 1536.0 
GO:2001189 BP 1.61e-04   2/214     3/29107 D09 negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell 10859.0, 84868.0 
GO:1905114 BP 1.61e-04   2/214     3/29107 D06 cell surface receptor signaling pathway involved in cell-cell signaling 718.0, 3684.0 
GO:0002553 BP 1.61e-04   2/214     3/29107 D09 histamine secretion by mast cell         695.0, 4067.0 
GO:2000406 BP 1.67e-04   3/214    15/29107 D11 positive regulation of T cell migration  199.0, 6693.0, 81704.0 
GO:0051279 BP 1.67e-04   3/214    15/29107 D09 regulation of release of sequestered calcium ion into cytosol 1535.0, 4067.0, 5777.0 
GO:0034142 BP 1.67e-04   3/214    15/29107 D08 toll-like receptor 4 signaling pathway   929.0, 4067.0, 118788.0 
GO:0016064 BP 1.67e-04   3/214    15/29107 D06 immunoglobulin mediated immune response  972.0, 3635.0, 10312.0 
GO:1901216 BP 1.72e-04   4/214    38/29107 D06 positive regulation of neuron death      712.0, 841.0, 3684.0, 3689.0 
GO:0045779 BP 2.04e-04   3/214    16/29107 D07 negative regulation of bone resorption   3635.0, 7128.0, 338773.0 
GO:0071361 BP 2.04e-04   3/214    16/29107 D06 cellular response to ethanol             113.0, 1536.0, 6688.0 
GO:0035556 BP 2.08e-04  11/214   402/29107 D05 intracellular signal transduction        113.0, 695.0, 3635.0, 3937.0, 4067.0, 5777.0, 6195.0, 6494.0, 6850.0, 23526.0, 29760.0 
GO:0031623 BP 2.32e-04   4/214    41/29107 D07 receptor internalization                 3689.0, 6850.0, 10859.0, 11006.0 
GO:0031668 BP 2.47e-04   3/214    17/29107 D04 cellular response to extracellular stimulus 199.0, 4067.0, 5788.0 
GO:0035855 BP 2.47e-04   3/214    17/29107 D05 megakaryocyte development                2313.0, 5777.0, 6886.0 
GO:0001516 BP 2.47e-04   3/214    17/29107 D11 prostaglandin biosynthetic process       972.0, 5742.0, 6916.0 
GO:0032720 BP 2.48e-04   5/214    76/29107 D09 negative regulation of tumor necrosis factor production 5777.0, 7128.0, 10859.0, 54209.0, 84868.0 
GO:0032689 BP 2.55e-04   4/214    42/29107 D08 negative regulation of interferon-gamma production 7805.0, 10859.0, 11006.0, 84868.0 
GO:0032691 BP 2.55e-04   4/214    42/29107 D09 negative regulation of interleukin-1 beta production 1524.0, 7128.0, 11006.0, 54209.0 
GO:0051897 BP 2.68e-04   6/214   120/29107 D08 positive regulation of protein kinase B signaling 1524.0, 2022.0, 5294.0, 7040.0, 23533.0, 64805.0 
GO:0002223 BP 2.95e-04   3/214    18/29107 D11 stimulatory C-type lectin receptor signaling pathway 4067.0, 6850.0, 64581.0 
GO:0043011 BP 2.95e-04   3/214    18/29107 D07 myeloid dendritic cell differentiation   4055.0, 6688.0, 7048.0 
GO:0002376 BP 3.06e-04   4/214    44/29107 D01 immune system process                    2212.0, 3394.0, 3663.0, 4973.0 
GO:0045963 BP 3.20e-04   2/214     4/29107 D08 negative regulation of dopamine metabolic process 3684.0, 3689.0 
GO:0002282 BP 3.20e-04   2/214     4/29107 D07 microglial cell activation involved in immune response 1524.0, 54209.0 
GO:0002902 BP 3.20e-04   2/214     4/29107 D09 regulation of B cell apoptotic process   695.0, 4067.0 
GO:1904044 BP 3.20e-04   2/214     4/29107 D08 response to aldosterone                  1535.0, 1536.0 
GO:0002291 BP 3.20e-04   2/214     4/29107 D07 T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell 10875.0, 54518.0 
GO:0045728 BP 3.20e-04   2/214     4/29107 D04 respiratory burst after phagocytosis     3055.0, 54209.0 
GO:0002316 BP 3.20e-04   2/214     4/29107 D10 follicular B cell differentiation        3394.0, 6688.0 
GO:0002366 BP 3.20e-04   2/214     4/29107 D04 leukocyte activation involved in immune response 6850.0, 64581.0 
GO:1904151 BP 3.20e-04   2/214     4/29107 D08 positive regulation of microglial cell mediated cytotoxicity 3684.0, 6688.0 
GO:0071260 BP 3.34e-04   5/214    81/29107 D05 cellular response to mechanical stimulus 841.0, 1535.0, 2022.0, 4055.0, 51284.0 
GO:0048015 BP 3.34e-04   4/214    45/29107 D07 phosphatidylinositol-mediated signaling  1436.0, 5294.0, 5330.0, 5724.0 
GO:0050766 BP 3.96e-04   4/214    47/29107 D07 positive regulation of phagocytosis      1535.0, 1794.0, 54209.0, 64581.0 
GO:0030218 BP 3.96e-04   4/214    47/29107 D05 erythrocyte differentiation              4067.0, 6688.0, 6886.0, 10320.0 
GO:0070542 BP 4.07e-04   3/214    20/29107 D05 response to fatty acid                   6916.0, 7097.0, 7351.0 
GO:0045088 BP 4.07e-04   3/214    20/29107 D06 regulation of innate immune response     841.0, 54209.0, 84282.0 
GO:0050901 BP 4.07e-04   3/214    20/29107 D06 leukocyte tethering or rolling           1524.0, 6404.0, 6693.0 
GO:0016477 BP 4.60e-04   8/214   243/29107 D04 cell migration                           2022.0, 3071.0, 3689.0, 3936.0, 4773.0, 5294.0, 7040.0, 7128.0 
GO:0032088 BP 4.90e-04   5/214    88/29107 D12 negative regulation of NF-kappaB transcription factor activity 140.0, 6688.0, 7128.0, 57413.0, 84868.0 
GO:0071726 BP 5.30e-04   2/214     5/29107 D08 cellular response to diacyl bacterial lipopeptide 929.0, 7097.0 
GO:1900426 BP 5.30e-04   2/214     5/29107 D07 positive regulation of defense response to bacterium 1535.0, 84868.0 
GO:0003209 BP 5.30e-04   2/214     5/29107 D04 cardiac atrium morphogenesis             2022.0, 54567.0 
GO:1905007 BP 5.30e-04   2/214     5/29107 D08 positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation 2022.0, 7048.0 
GO:0033004 BP 5.30e-04   2/214     5/29107 D07 negative regulation of mast cell activation 8832.0, 284021.0 
GO:0071396 BP 5.30e-04   2/214     5/29107 D05 cellular response to lipid               6850.0, 54209.0 
GO:0034134 BP 5.30e-04   2/214     5/29107 D08 toll-like receptor 2 signaling pathway   7097.0, 118788.0 
GO:0043124 BP 5.42e-04   4/214    51/29107 D08 negative regulation of I-kappaB kinase/NF-kappaB signaling 841.0, 7128.0, 11006.0, 54209.0 
GO:0030031 BP 5.44e-04   3/214    22/29107 D05 cell projection assembly                 391.0, 3071.0, 85477.0 
GO:0051090 BP 5.44e-04   3/214    22/29107 D10 regulation of DNA-binding transcription factor activity 3055.0, 6688.0, 6850.0 
GO:0050860 BP 5.44e-04   3/214    22/29107 D08 negative regulation of T cell receptor signaling pathway 5777.0, 7805.0, 11006.0 
GO:0071346 BP 6.00e-04   5/214    92/29107 D06 cellular response to interferon-gamma    199.0, 3113.0, 3394.0, 4641.0, 7097.0 
GO:0042127 BP 6.10e-04   6/214   140/29107 D04 regulation of cell population proliferation 2242.0, 5742.0, 6776.0, 6886.0, 7040.0, 7048.0 
GO:0006968 BP 6.27e-04   4/214    53/29107 D04 cellular defense response                1524.0, 4332.0, 6693.0, 10312.0 
GO:0031334 BP 6.74e-04   4/214    54/29107 D06 positive regulation of protein-containing complex assembly 6850.0, 6886.0, 7040.0, 64581.0 
GO:0090023 BP 7.08e-04   3/214    24/29107 D11 positive regulation of neutrophil chemotaxis 719.0, 972.0, 3071.0 
GO:0070821 CC 6.68e-08  11/214    73/29107 D07 tertiary granule membrane                963.0, 1535.0, 1536.0, 3684.0, 3687.0, 3689.0, 3903.0, 4973.0, 5724.0, 11322.0, 22918.0 
GO:0042613 CC 1.18e-07   5/214    17/29107 D05 MHC class II protein complex             972.0, 3108.0, 3109.0, 3113.0, 3122.0 
GO:0045121 CC 2.43e-07  16/214   240/29107 D04 membrane raft                            684.0, 695.0, 841.0, 920.0, 929.0, 3635.0, 4067.0, 4641.0, 4973.0, 5788.0, 7048.0, 7096.0, 7097.0, 7133.0, 10287.0, 84433.0 
GO:0009897 CC 3.25e-07  20/214   295/29107 D03 external side of plasma membrane         920.0, 929.0, 942.0, 972.0, 1441.0, 1524.0, 2022.0, 2214.0, 2217.0, 3597.0, 3684.0, 3687.0, 3689.0, 4481.0, 5788.0, 6693.0, 7048.0, 8748.0, 10859.0, 64805.0 
GO:0009986 CC 3.30e-07  25/214   579/29107 D02 cell surface                             684.0, 718.0, 942.0, 963.0, 972.0, 1436.0, 1524.0, 2022.0, 3108.0, 3113.0, 3122.0, 3678.0, 3684.0, 3687.0, 3689.0, 5788.0, 6693.0, 7040.0, 7094.0, 7097.0, 11006.0, 22918.0, 64581.0, 64805.0, 84868.0 
GO:0035579 CC 3.77e-07  12/214    91/29107 D07 specific granule membrane                719.0, 963.0, 1535.0, 1536.0, 3684.0, 3689.0, 3903.0, 4973.0, 6518.0, 7133.0, 11322.0, 22918.0 
GO:0005887 CC 5.20e-07  40/214  1403/29107 D04 integral component of plasma membrane    113.0, 140.0, 719.0, 920.0, 963.0, 1436.0, 1441.0, 1524.0, 1536.0, 2212.0, 2214.0, 2857.0, 3071.0, 3113.0, 3122.0, 4481.0, 4973.0, 5724.0, 5788.0, 6404.0, 6518.0, 6693.0, 7048.0, 7096.0, 7097.0, 7805.0, 8832.0, 10161.0, 10261.0, 10312.0, 10894.0, 11309.0, 11322.0, 23166.0, 27094.0, 54209.0, 57413.0, 81793.0, 147138.0, 284021.0 
GO:0030667 CC 6.18e-07  10/214    97/29107 D06 secretory granule membrane               391.0, 929.0, 2212.0, 3071.0, 3687.0, 5724.0, 5788.0, 7097.0, 22918.0, 340061.0 
GO:0016020 CC 8.60e-07  40/214  2120/29107 D02 membrane                                 397.0, 684.0, 972.0, 1535.0, 1794.0, 1967.0, 3071.0, 3099.0, 3108.0, 3687.0, 3689.0, 4174.0, 4641.0, 4973.0, 5294.0, 5724.0, 5777.0, 5788.0, 6404.0, 6494.0, 6693.0, 7096.0, 7133.0, 8365.0, 9902.0, 10287.0, 10894.0, 23526.0, 23533.0, 29760.0, 50619.0, 57413.0, 58191.0, 64926.0, 79690.0, 80346.0, 81704.0, 81793.0, 83706.0, 118788.0 
GO:0030666 CC 9.39e-07   7/214    71/29107 D06 endocytic vesicle membrane               972.0, 1441.0, 3113.0, 3122.0, 4067.0, 4481.0, 23166.0 
GO:0070062 CC 1.39e-06  44/214  2169/29107 D06 extracellular exosome                    391.0, 397.0, 684.0, 718.0, 720.0, 929.0, 942.0, 963.0, 972.0, 1794.0, 2214.0, 3071.0, 3122.0, 3684.0, 3689.0, 3936.0, 4067.0, 4332.0, 4641.0, 5742.0, 5777.0, 5788.0, 5836.0, 6518.0, 6693.0, 6696.0, 7094.0, 7128.0, 8365.0, 8857.0, 10095.0, 10875.0, 10894.0, 11006.0, 11322.0, 22977.0, 26509.0, 64926.0, 79690.0, 83706.0, 84433.0, 85477.0, 147138.0, 219855.0 
GO:0005829 CC 1.75e-06  73/214  5295/29107 D02 cytosol                                  199.0, 240.0, 391.0, 397.0, 684.0, 695.0, 841.0, 843.0, 860.0, 1794.0, 1967.0, 2242.0, 2313.0, 2533.0, 3055.0, 3071.0, 3099.0, 3394.0, 3587.0, 3635.0, 3663.0, 3936.0, 3937.0, 4067.0, 4174.0, 4261.0, 4332.0, 4481.0, 4542.0, 4641.0, 4773.0, 5294.0, 5330.0, 5777.0, 5836.0, 5866.0, 6001.0, 6195.0, 6494.0, 6776.0, 6850.0, 7048.0, 7094.0, 7128.0, 7318.0, 7409.0, 7805.0, 10095.0, 10320.0, 10346.0, 10475.0, 22977.0, 23526.0, 23533.0, 27128.0, 29760.0, 50619.0, 51699.0, 54518.0, 64092.0, 64926.0, 81704.0, 84282.0, 84433.0, 89846.0, 90167.0, 115004.0, 117289.0, 118788.0, 123920.0, 221472.0, 257106.0, 340061.0 
GO:0005886 CC 2.30e-06 104/214  4487/29107 D03 plasma membrane                          113.0, 140.0, 391.0, 684.0, 695.0, 718.0, 719.0, 720.0, 920.0, 929.0, 942.0, 963.0, 972.0, 1436.0, 1441.0, 1524.0, 1535.0, 1536.0, 1967.0, 2022.0, 2212.0, 2214.0, 2533.0, 2769.0, 3055.0, 3071.0, 3099.0, 3113.0, 3122.0, 3587.0, 3597.0, 3635.0, 3678.0, 3684.0, 3687.0, 3689.0, 3903.0, 3936.0, 4055.0, 4067.0, 4481.0, 4542.0, 4641.0, 4973.0, 5294.0, 5724.0, 5788.0, 6001.0, 6404.0, 6518.0, 6693.0, 6850.0, 7040.0, 7048.0, 7094.0, 7096.0, 7097.0, 7133.0, 7409.0, 8748.0, 8832.0, 10161.0, 10287.0, 10312.0, 10859.0, 10863.0, 10894.0, 11006.0, 11309.0, 11322.0, 22918.0, 23166.0, 23533.0, 26509.0, 27094.0, 27128.0, 27181.0, 29760.0, 50619.0, 51284.0, 51411.0, 53829.0, 54209.0, 54518.0, 54567.0, 54947.0, 55803.0, 57121.0, 57413.0, 58191.0, 64581.0, 64805.0, 79651.0, 80342.0, 81793.0, 84106.0, 84433.0, 85477.0, 89790.0, 90167.0, 115004.0, 118788.0, 338773.0, 340061.0 
GO:0016021 CC 2.45e-06  55/214  3536/29107 D03 integral component of membrane           113.0, 684.0, 942.0, 972.0, 2022.0, 2217.0, 3108.0, 3109.0, 3587.0, 3903.0, 4055.0, 4481.0, 4814.0, 5724.0, 5788.0, 6404.0, 6916.0, 7048.0, 7133.0, 7351.0, 8748.0, 9902.0, 10859.0, 10863.0, 11326.0, 22918.0, 26509.0, 27181.0, 51284.0, 51296.0, 53346.0, 53829.0, 54209.0, 54567.0, 54947.0, 57121.0, 58191.0, 58475.0, 64231.0, 64581.0, 64805.0, 79651.0, 79690.0, 80342.0, 80346.0, 84002.0, 84868.0, 89790.0, 122618.0, 123920.0, 170371.0, 203260.0, 219972.0, 338773.0, 727866.0 
GO:0005576 CC 2.92e-06  33/214  1854/29107 D02 extracellular region                     240.0, 313.0, 341.0, 712.0, 713.0, 714.0, 718.0, 720.0, 929.0, 1296.0, 1441.0, 1520.0, 1794.0, 4332.0, 4814.0, 4973.0, 5777.0, 5836.0, 6696.0, 7040.0, 7094.0, 7133.0, 8365.0, 10859.0, 10863.0, 10875.0, 23526.0, 51411.0, 54209.0, 58191.0, 83706.0, 89790.0, 219972.0 
GO:0044853 CC 4.11e-06   5/214    33/29107 D05 plasma membrane raft                     3684.0, 3689.0, 3937.0, 6404.0, 54209.0 
GO:0001726 CC 6.27e-06   7/214    94/29107 D04 ruffle                                   199.0, 3678.0, 3936.0, 7094.0, 64092.0, 89846.0, 221472.0 
GO:0005765 CC 6.96e-06  12/214   331/29107 D07 lysosomal membrane                       972.0, 1441.0, 3108.0, 3109.0, 3113.0, 3122.0, 4067.0, 7805.0, 10312.0, 51296.0, 53346.0, 80342.0 
GO:0032587 CC 8.84e-06   7/214    99/29107 D05 ruffle membrane                          199.0, 3678.0, 3936.0, 4641.0, 7094.0, 23526.0, 221472.0 
GO:0005925 CC 1.48e-05  13/214   418/29107 D05 focal adhesion                           391.0, 1535.0, 2022.0, 2242.0, 3055.0, 3678.0, 3689.0, 3936.0, 5788.0, 7094.0, 9902.0, 10095.0, 54518.0 
GO:0043231 CC 1.76e-05  19/214   846/29107 D04 intracellular membrane-bounded organelle 313.0, 861.0, 1436.0, 1520.0, 3055.0, 3099.0, 3108.0, 3109.0, 3113.0, 4067.0, 4332.0, 4973.0, 5742.0, 8832.0, 26509.0, 51296.0, 51699.0, 55803.0, 257106.0 
GO:0008305 CC 3.18e-05   4/214    25/29107 D05 integrin complex                         3678.0, 3684.0, 3687.0, 3689.0 
GO:0042995 CC 4.24e-05   7/214   126/29107 D02 cell projection                          391.0, 3055.0, 6696.0, 7097.0, 51411.0, 83706.0, 85477.0 
GO:0005794 CC 4.57e-05  20/214   988/29107 D05 Golgi apparatus                          684.0, 929.0, 1535.0, 1536.0, 2212.0, 2242.0, 3055.0, 4055.0, 4067.0, 5742.0, 6696.0, 7096.0, 7097.0, 10287.0, 10346.0, 11322.0, 89846.0, 147138.0, 221472.0, 340061.0 
GO:0002102 CC 5.06e-05   4/214    28/29107 D05 podosome                                 3936.0, 51411.0, 83706.0, 85477.0 
GO:0001891 CC 5.06e-05   4/214    28/29107 D02 phagocytic cup                           199.0, 3936.0, 9938.0, 51411.0 
GO:0034688 CC 5.38e-05   2/214     2/29107 D06 integrin alphaM-beta2 complex            3684.0, 3689.0 
GO:0034689 CC 5.38e-05   2/214     2/29107 D06 integrin alphaX-beta2 complex            3687.0, 3689.0 
GO:0005602 CC 5.38e-05   2/214     2/29107 D02 complement component C1 complex          712.0, 713.0 
GO:0035354 CC 5.38e-05   2/214     2/29107 D05 Toll-like receptor 1-Toll-like receptor 2 protein complex 7096.0, 7097.0 
GO:0042101 CC 6.19e-05   3/214    11/29107 D05 T cell receptor complex                  920.0, 6850.0, 54518.0 
GO:0031410 CC 6.77e-05  10/214   293/29107 D06 cytoplasmic vesicle                      313.0, 391.0, 397.0, 695.0, 2242.0, 7805.0, 26509.0, 123920.0, 219972.0, 257106.0 
GO:0005581 CC 8.06e-05   5/214    60/29107 D02 collagen trimer                          712.0, 713.0, 714.0, 1296.0, 4481.0 
GO:0101003 CC 8.73e-05   5/214    61/29107 D07 ficolin-1-rich granule membrane          3071.0, 3687.0, 3689.0, 10312.0, 22918.0 
GO:0043235 CC 1.67e-04   8/214   209/29107 D02 receptor complex                         1436.0, 1441.0, 2022.0, 3597.0, 3689.0, 4973.0, 7048.0, 51284.0 
GO:0030670 CC 1.92e-04   5/214    72/29107 D07 phagocytic vesicle membrane              1535.0, 1536.0, 7096.0, 7097.0, 10312.0 
GO:0005856 CC 2.04e-04  11/214   401/29107 D05 cytoskeleton                             391.0, 397.0, 841.0, 1794.0, 3635.0, 7094.0, 50619.0, 54518.0, 89846.0, 90167.0, 221472.0 
GO:0001772 CC 2.80e-04   4/214    43/29107 D02 immunological synapse                    963.0, 3122.0, 84433.0, 84868.0 
GO:0005944 CC 3.20e-04   2/214     4/29107 D07 phosphatidylinositol 3-kinase complex, class IB 5294.0, 23533.0 
GO:1904813 CC 3.20e-04   6/214   124/29107 D05 ficolin-1-rich granule lumen             240.0, 1520.0, 4332.0, 5836.0, 10875.0, 51411.0 
GO:0031265 CC 7.92e-04   2/214     6/29107 D05 CD95 death-inducing signaling complex    841.0, 843.0 
GO:0097342 CC 7.92e-04   2/214     6/29107 D03 ripoptosome                              841.0, 843.0 
GO:0032991 CC 1.01e-03  13/214   643/29107 D01 protein-containing complex               718.0, 841.0, 972.0, 2533.0, 5777.0, 6494.0, 6850.0, 7805.0, 8365.0, 10320.0, 11326.0, 84106.0, 85477.0 
GO:0016461 CC 1.10e-03   2/214     7/29107 D03 unconventional myosin complex            4542.0, 4641.0 
GO:0071556 CC 1.12e-03   3/214    28/29107 D06 integral component of lumenal side of endoplasmic reticulum membrane 972.0, 3113.0, 3122.0 
GO:0045335 CC 1.28e-03   4/214    64/29107 D08 phagocytic vesicle                       1520.0, 4641.0, 122618.0, 219972.0 
GO:0023026 MF 3.83e-08   6/214    27/29107 D04 MHC class II protein complex binding     920.0, 972.0, 3108.0, 3109.0, 3113.0, 3122.0 
GO:0004888 MF 2.73e-07  15/214   157/29107 D03 transmembrane signaling receptor activity 920.0, 2022.0, 2212.0, 2214.0, 6693.0, 7096.0, 7097.0, 10261.0, 10894.0, 27181.0, 51284.0, 54209.0, 57413.0, 81793.0, 284021.0 
GO:0038023 MF 4.69e-07  12/214   209/29107 D02 signaling receptor activity              920.0, 942.0, 1441.0, 3587.0, 3687.0, 7096.0, 7097.0, 9902.0, 10894.0, 22918.0, 54209.0, 81793.0 
GO:0005085 MF 8.90e-07  12/214   223/29107 D06 guanyl-nucleotide exchange factor activity 1794.0, 1967.0, 5866.0, 7409.0, 27128.0, 50619.0, 64805.0, 81704.0, 89846.0, 90167.0, 117289.0, 221472.0 
GO:0005178 MF 1.14e-06   9/214   142/29107 D04 integrin binding                         3684.0, 3687.0, 3689.0, 3936.0, 4067.0, 6696.0, 6850.0, 7094.0, 83706.0 
GO:0045028 MF 1.34e-06   4/214    12/29107 D06 G protein-coupled purinergic nucleotide receptor activity 2857.0, 5724.0, 53829.0, 64805.0 
GO:0005515 MF 2.82e-06 160/214 12418/29107 D02 protein binding                          199.0, 240.0, 313.0, 341.0, 391.0, 397.0, 678.0, 684.0, 695.0, 712.0, 713.0, 714.0, 718.0, 841.0, 843.0, 860.0, 861.0, 920.0, 929.0, 942.0, 963.0, 972.0, 1436.0, 1441.0, 1524.0, 1535.0, 1536.0, 1794.0, 1967.0, 2022.0, 2212.0, 2217.0, 2242.0, 2313.0, 2533.0, 3055.0, 3071.0, 3099.0, 3108.0, 3109.0, 3122.0, 3394.0, 3587.0, 3597.0, 3635.0, 3663.0, 3678.0, 3684.0, 3687.0, 3689.0, 3903.0, 3937.0, 4055.0, 4067.0, 4174.0, 4261.0, 4332.0, 4481.0, 4542.0, 4641.0, 4773.0, 4814.0, 4973.0, 5294.0, 5330.0, 5742.0, 5777.0, 5788.0, 5836.0, 5866.0, 6001.0, 6195.0, 6404.0, 6494.0, 6518.0, 6672.0, 6688.0, 6693.0, 6696.0, 6776.0, 6850.0, 6886.0, 7040.0, 7048.0, 7094.0, 7096.0, 7097.0, 7128.0, 7133.0, 7164.0, 7318.0, 7351.0, 7409.0, 7805.0, 8365.0, 8832.0, 8857.0, 9902.0, 10095.0, 10161.0, 10287.0, 10312.0, 10320.0, 10346.0, 10475.0, 10859.0, 10863.0, 10894.0, 11006.0, 11322.0, 11326.0, 22797.0, 22918.0, 22977.0, 23166.0, 23526.0, 26509.0, 27128.0, 27181.0, 29760.0, 50619.0, 51284.0, 51296.0, 51411.0, 51699.0, 53829.0, 54209.0, 54502.0, 54518.0, 54567.0, 54947.0, 55803.0, 58475.0, 64231.0, 64581.0, 64926.0, 79651.0, 80342.0, 80346.0, 81704.0, 81793.0, 84002.0, 84106.0, 84282.0, 84433.0, 84868.0, 89790.0, 89857.0, 90167.0, 115004.0, 117289.0, 118788.0, 123920.0, 147138.0, 157777.0, 203260.0, 221472.0, 284021.0, 340061.0, 727866.0 
GO:0001540 MF 2.95e-06   7/214    84/29107 D04 amyloid-beta binding                     712.0, 972.0, 3684.0, 3689.0, 4481.0, 7097.0, 54209.0 
GO:0140031 MF 3.88e-06   3/214     5/29107 D04 phosphorylation-dependent protein binding 4067.0, 5777.0, 7409.0 
GO:0140311 MF 3.88e-06   3/214     5/29107 D02 protein sequestering activity            6688.0, 7805.0, 147138.0 
GO:0001851 MF 3.88e-06   3/214     5/29107 D04 complement component C3b binding         3684.0, 3689.0, 11326.0 
GO:0001530 MF 4.11e-06   5/214    33/29107 D03 lipopolysaccharide binding               929.0, 4814.0, 5724.0, 7097.0, 54209.0 
GO:0042802 MF 5.44e-06  28/214  1494/29107 D03 identical protein binding                684.0, 695.0, 841.0, 920.0, 963.0, 972.0, 1967.0, 2022.0, 3663.0, 4055.0, 4973.0, 5294.0, 5836.0, 5866.0, 6672.0, 7040.0, 7096.0, 7097.0, 7128.0, 7164.0, 8832.0, 10346.0, 22977.0, 64926.0, 81793.0, 84282.0, 118788.0, 340061.0 
GO:0042169 MF 1.09e-05   5/214    40/29107 D04 SH2 domain binding                       5777.0, 6850.0, 10859.0, 29760.0, 89790.0 
GO:0001784 MF 1.76e-05   5/214    44/29107 D05 phosphotyrosine residue binding          3055.0, 5777.0, 6850.0, 7409.0, 64092.0 
GO:0004713 MF 1.94e-05   6/214    75/29107 D06 protein tyrosine kinase activity         695.0, 1436.0, 2242.0, 3055.0, 4067.0, 6850.0 
GO:0004715 MF 1.97e-05   5/214    45/29107 D07 non-membrane spanning protein tyrosine kinase activity 695.0, 2242.0, 3055.0, 4067.0, 6850.0 
GO:0005096 MF 2.17e-05  10/214   256/29107 D05 GTPase activator activity                397.0, 3071.0, 6001.0, 6494.0, 9938.0, 23526.0, 55803.0, 64926.0, 117289.0, 257106.0 
GO:0019864 MF 3.19e-05   3/214     9/29107 D04 IgG binding                              2212.0, 2214.0, 2217.0 
GO:0034713 MF 4.53e-05   3/214    10/29107 D06 type I transforming growth factor beta receptor binding 2022.0, 7040.0, 7048.0 
GO:0005102 MF 6.50e-05  11/214   352/29107 D03 signaling receptor binding               718.0, 2242.0, 2533.0, 3055.0, 4067.0, 4641.0, 5788.0, 6404.0, 6850.0, 10875.0, 118788.0 
GO:0005041 MF 1.67e-04   3/214    15/29107 D03 low-density lipoprotein particle receptor activity 4973.0, 23166.0, 58191.0 
GO:0019901 MF 2.00e-04  12/214   469/29107 D05 protein kinase binding                   391.0, 920.0, 3663.0, 3689.0, 5777.0, 5788.0, 6850.0, 10346.0, 10475.0, 29760.0, 84106.0, 340061.0 
GO:0004714 MF 2.03e-04   6/214   114/29107 D07 transmembrane receptor protein tyrosine kinase activity 695.0, 1436.0, 2242.0, 3055.0, 4067.0, 6850.0 
GO:0061809 MF 2.04e-04   3/214    16/29107 D06 NAD+ nucleotidase, cyclic ADP-ribose generating 7096.0, 7097.0, 81793.0 
GO:0038187 MF 2.04e-04   3/214    16/29107 D03 pattern recognition receptor activity    7097.0, 51284.0, 64581.0 
GO:0050135 MF 2.04e-04   3/214    16/29107 D05 NAD(P)+ nucleosidase activity            7096.0, 7097.0, 81793.0 
GO:0038024 MF 2.04e-04   3/214    16/29107 D01 cargo receptor activity                  3684.0, 3689.0, 4481.0 
GO:0019955 MF 2.32e-04   4/214    41/29107 D03 cytokine binding                         972.0, 1436.0, 1441.0, 3597.0 
GO:0030169 MF 2.47e-04   3/214    17/29107 D05 low-density lipoprotein particle binding 4481.0, 23166.0, 54209.0 
GO:0070891 MF 3.20e-04   2/214     4/29107 D03 lipoteichoic acid binding                929.0, 54209.0 
GO:0035877 MF 3.20e-04   2/214     4/29107 D04 death effector domain binding            841.0, 843.0 
GO:0004896 MF 3.64e-04   4/214    46/29107 D04 cytokine receptor activity               972.0, 1441.0, 3587.0, 3597.0 
